Date: August 06, 2026
Board Meeting Outcomes
- The Board of Directors meeting held on August 06, 2026 approved a further investment of up to INR 16 Crore in HCG Rajkot Hospitals LLP, a wholly owned subsidiary of the Company
- The meeting commenced at 11:30 a.m. and concluded at 6:50 p.m. IST
Investment Details
Target Entity Profile
- Name: HCG Rajkot Hospitals LLP
- Business: Operates a cancer-specialty hospital in Rajkot, Gujarat, India
- Licensed capacity: 147 beds (134 beds operational as of date)
- Date of incorporation: September 22, 2017
- Financial performance:
- FY2026 revenue: INR 60.67 Crore
- FY2025 revenue: INR 55.49 Crore
- FY2024 revenue: INR 55.37 Crore
Transaction Specifics
- Investment amount: Up to INR 16 Crore
- Consideration form: Cash
- Completion timeline: On or before September 30, 2026
- Post-investment ownership: Company will continue to hold 100% of the capital
- Purpose: Repayment of dues, working capital, and general corporate purposes
Regulatory Aspects
- Regulatory reference: SEBI (LODR) Regulations, 2015 Regulation 30(2) and (6) read with Schedule III Part A Para A sub-para (1)
- SEBI Master Circular: HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 issued on July 11, 2023, last updated January 30, 2026
- Transaction classification: Related party transaction (as HCG Rajkot is wholly owned subsidiary)
- Execution basis: Arm's length basis
- Government approvals: No governmental or regulatory approvals required
- Promoter interest: No promoter/promoter group/group companies have any interest beyond the subsidiary relationship